Q4 2025 Earnings Call February 5, 2026 8:15 AM ESTCompany ParticipantsMaziar Doustdar - President, CEO & Member of ...
Need a quote from a Motley Fool analyst? Although Synaptics believes that estimates and assumptions underlying these ...
ZenaTech (NASDAQ:ZENA) executives outlined the company’s evolving business mix, acquisition strategy, and defense-market ...
AMT-191 has been granted both Orphan Drug and Fast Track designation by the U.S. Food and Drug Administration.
Supraphysiological expression of α-Gal A activity maintained for over a year in longest treated patient as of data cutoff date ~~ Stable ...
TrumpRx costs may be as much as 80% less than normal listings, though actual savings may differ.